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Objectives: The benefits of coronary artery bypass surgery depend on lasting graft patency. 
To aid rational graft selection, the relative long-term merits of radial artery and saphenous 
vein grafts need to be determined by a gold standard method and with minimal clinically 
driven selection bias. 
Methods: The patency rates of various conduits were determined by direct angiography in 76 
patients from a cohort of 119 undergoing coronary artery bypass grafting 7.6 – 12.1 (mean 
8.9) years before. 
Results: 14 out of 76 radial artery and 10 out of 61 saphenous vein grafts were occluded (rates 
0.18 and 0.16, respectively). 
Conclusion: The high long-term patency rate of saphenous vein grafts does not support a 
preferential use of the radial artery as a coronary artery bypass conduit.  
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The saphenous vein and the radial artery are alternative conduits to complement internal 
mammary artery (IMA) grafting in coronary bypass surgery. Their relative merits would best 
be determined by prospective monitoring of long-term patency by direct angiography, the 
gold standard method for graft evaluation, in a patient cohort with high a follow-up rate and 
minimal clinically driven selection bias. Accordingly, in order to facilitate rational conduit 
selection, we designed the Radial Artery BypAss GrAft Study of Tromsø (RABAGAST) [1] 
and here report angiographic patency rates 8-12 years post-operatively. 
Materials and methods 
When the University Hospital North Norway took up radial artery grafting, all patients 
revascularized this way from April 4 2001 to October 7 2003 (119 out of 811 isolated CABG 
operations), were included in the study protocol. Our CABG program had been running for 23 
years, and the annual volume of open-heart surgeries was 600 cases. The patient 
characteristics, ethics approval, angiographic evaluation, and computerized data analysis have 
been described together with clinical outcomes and graft patency rates after 1.3 – 3.9 years 
[1]. The staff was advised to graft the LAD with the left IMA (LIMA) in the presence of 
significant left main or left anterior descending branch pathology and to consider the use of at 
least one additional arterial graft in dual or triple vessel disease patients < 65 years of age and 
in those without a suitable saphenous vein [1]. All grafts were harvested by open (not 
endoscopic) technique. Whether to use the radial artery and choice of coronary target territory 
was at the discretion of the surgeon. 111 patients (93 %) received at least one IMA graft and 
84 (71 %) at least one saphenous vein graft in addition to the radial artery conduit. 108 radial 
arteries were proximally anastomosed to the ascending aorta, 7 to a LIMA and 4 to a 
saphenous vein graft. They were mostly used for the left coronary artery territory whereas the 
predominant targets of saphenous vein grafts were right coronary artery branches. 
 
Specifically, the radial artery targets were 97 circumflex/intermediate, 28 right coronary 
artery (including 17 descending posterior and 7 main stem), 22 diagonal, and three left 
anterior descending branches. The targets of the saphenous vein grafts were 69 right coronary 
artery (including 51 descending posterior and 3 main stem), 23 circumflex/intermediate, one 
left anterior descending and 20 diagonal branches. Amlodipine was routinely prescribed 
postoperatively as it was assumed to mitigate graft spasm. 
Long-term follow-up included direct angiography when not contraindicated. Angiograms 
were thus obtained solely for the study purpose 7.6 – 12.1 (mean 8.9) years postoperatively in 
76 patients (64 % of the original cohort, 74 % of those alive). Each segment of a sequence 
graft was counted as an individual bypass. Grafts and bypasses were classified as open (lumen 
diameter > 50 % of normal along entire length), stenotic (opacification with contrast along 
entire length, but lumen diameter < 50 %), or occluded (none or discontinuous opacification).  
Vital status and cause of death, verified by autopsy in 7 cases, were collected form the patient 
records or The Norwegian Institute of Public Health. 
Statistical analyses were performed with the SPSS® software (SPSS Inc., Chicago, IL). 
Results 
78 patients (66 %) were alive 16.3 years after the index operation (Fig. 1). Ischemic heart 
disease was the most common cause of death (16 out of 41).  
7.6 – 12.1 years post-operatively, 14 out of 76 radial artery and 10 out of 61 saphenous vein 
grafts were occluded (rates 0.18 and 0.16, respectively) (Fig. 2, upper panel). 75 out of 83 
IMA grafts remained open without stenosis (occlusion rate 0.08). Occlusion rates were 0.16 
for radial artery and 0.14 for saphenous vein bypasses (Fig. 2, lower panel). Equal long-term 
 
performance of radial artery and saphenous vein was evident also when restricting the 
analysis to those patients who had both types of conduits (Fig. 3).  
Although the patency of radial artery and saphenous vein grafts were equal at follow-up, the 
possibility remained that the time to occlusion differed among them so as to render the arterial 
graft to be preferred. However, in a time-to-event analysis, the durability of the saphenous 
veins were not inferior to that of radial arteries (Fig. 4).  
In contrast to saphenous vein grafts, all arterial grafts that were anastomosed to a proximally 
occluded target vessel, maintained long-term patency (Table 1). 
Discussion 
Their susceptibility to atherosclerotic degeneration limits the durability of aortocoronary vein 
grafts [2]. Being resistant to atherosclerosis, the radial artery is an attractive alternative [3, 4] 
and its use for high-grade stenotic target vessel grafting has a class I ESC/EACTS guideline 
recommendation [5]. But clinical outcomes studies are inconsistent and graft failure rates vary 
widely in the range of 17-37 % beyond 10 years [2, 4]. It is unclear whether any perceived 
benefit of radial artery over saphenous vein grafting reflects inherent conduit characteristics 
or rather results from confounders like treatment allocation bias [4]. To unequivocally clarify 
whether distinct biological properties translate into different long-term patency of various 
graft types, their merits should be compared in the same patient with the same method during 
the same interval of time. This would eliminate confounding effects of patient, treatment, and 
evaluation variables. Any selection bias should be mitigated by high follow-up rates and an 
evaluation protocol minimally affected by clinical events. In the present long-term 
comparison of radial and saphenous vein grafts, target vessel properties remained the only 
potential confounder in those 53 out of 76 patients subjected to protocol-directed angiography 
who had both graft types. As we were inclined to prioritize arterial over saphenous vein 
 
grafting of the obstructed coronary arteries with large diameters and territories, it is unlikely 
that saphenous vein patency was maintained by better distal run-off. Thus, our finding that 
radial artery and saphenous vein grafts have equal long-term patency is robust. The data 
corroborate the only randomized radial artery graft trial reporting long-term data with high 
follow up-rates and exclusively protocol-driven angiographic evaluation [4 (review), 6]. The 
favorable results with saphenous vein grafts may reflect our procurement protocol, which 
includes irrigation and storage in autologous blood (30 %) and papaverine (0.6 mg/mL) [1]. 
A meta-analysis [7] of earlier randomized controlled trials [8-13] concluded that radial artery 
grafts were superior to vein grafts at 50±30 months. In particular, excellent radial artery graft 
patency considerably better than that of saphenous vein (occlusion rates 9 and 19 %, 
respectively) was achieved in a randomized trial with a follow up-rate of 75 % and 91 % 
protocol-directed angiographies 7.7 ± 1.5 years postoperatively [11]. The study populations 
differed somewhat from the RABAGAST cohort with respect to risk factors for intermediate-
term radial artery graft occlusion [1, 14]. Risk factors for late graft failure will be reported 
(Bahar et al., in preparation), and may explain patency discrepancies.  
 
Radial artery grafts appear vulnerable to occlusion when the target vessel stenosis is only 
moderate [15]. Strikingly, we found that all radial arteries grafted to proximally occluded 
targets remained patent after 7.6 – 12.1 years. Although not statistically significant, this 
observation supports the contention that the degree of native flow obstruction impacts long-
term graft patency. Accordingly, dissimilar target vessel properties and revascularization 
strategies may contribute to differences in graft patency across various trials. 
 
The vein graft patency rates of the RABAGAST study compares favorably with those of the 
EPICS [16] and PREVENT-IV [17] randomized trials. We assume that this was mainly due to 
 
a lower proportion of diabetics among RABAGAST participants (10 % [1] vs. 37 % and 36 % 
in EPICS [16] and PREVENT-IV [17], respectively), since diabetes mellitus impairs run-off 
by inducing microangiopathy and potentiating target vessel atherosclerosis and also 
accelerates saphenous vein graft degeneration [18, 19]. In addition, an open graft harvesting 
technique most likely contributed to the higher patency rate in the RABAGAST trial, as the 
endoscopic procedures used in the majority of EPICS and PREVENT-IV participants (62 % 
and 55 %, respectively) were associated with vein graft failure [16, 17, reviewed in 20]. 
 
The saphenous vein is the most widely used coronary artery bypass graft and the only conduit 
in addition to the IMA in more than 90 % of cases [21]. The RABAGAST study provides 
evidence to support this practice. 
 
Conclusion 
In our study the long term patency rates of saphenous vein grafts and radial artery grafts were 
similar. The high long term patency rate of saphenous vein grafts in our study does not 
support preferential use of the radial artery.  Both conduits are equally effective when 
appropriately harvested and used. 
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Table 1. Preoperative target vessel occlusion and conduit patency 7.6 – 12.1 years after radial artery grafting of the coronary circulation 
 
  Graft status at per protocol angiography 
  IMA Radial artery Saphenous vein 





Stenotic   60   7   51   14   37   6 
Occluded   16   0   11   0   14   4 
 Sum   76   7   62   14   51   10 
 
Preoperative target vessel obstruction (stenotic or occluded) and long-term graft patency (open with or without stenosis, or occluded) is shown 
for the 76 patients subjected to direct angiography per protocol out of the 119 included in the RABAGAST trial. IMA: internal mammary artery. 
For IMA grafts, P = 0.34; radial artery grafts, P = 0.20; arterial grafts combined, P = 0.027; saphenous vein grafts P = 0.46 (Fisher`s exact test).   
 
Legends 
Figure 1. Mortality after radial artery grafting of the coronary circulation 
The number of patients alive is depicted as a function of time after coronary bypass surgery 
with a radial artery graft. Each patient who died during follow-up (•) and the cause of death is 
indicated. 
 
Figure 2. Patency after radial artery grafting of the coronary circulation 
Out of 119 patients included in the study, 76 underwent direct angiography per protocol 7.6 – 
12.1 (mean 8.9) years after the index operation. 177 single and 43 sequence grafts were 
examined. Each segment of a sequence graft was counted as an individual bypass. On each 
column is depicted the number of grafts (upper panel) and bypasses (lower panel) open 
without stenosis, stenotic, and occluded, respectively. Their relative proportions (%) are given 
on the ordinate. n.d: distal segments of sequence grafts that were indeterminate due to 
occlusion of the proximal segment; L(R)IMA: left (right) internal mammary artery. For 
occluded vs. non-occluded radial artery and saphenous vein grafts, P = 0.76, for bypasses, P = 
0.73 (chi square testa). 
 
Figure 3. Direct comparison of conduit patencies in patients receiving an internal mammary 
artery or a saphenous vein in addition to a radial artery graft to the coronary circulation 
 
a The statistical analyses were not adjusted for potential within-subject dependence. 
 
 
Conduit patencies are shown for those patients out of a study cohort of 119 who per protocol 
underwent direct angiography 7.6 – 12.1 (mean 8.9) years after radial artery grafting and also 
had an internal mammary artery (IMA) or a saphenous vein graft (73 and 53 patients, 
respectively). Each segment of a sequence graft was counted as an individual bypass. On each 
column is depicted the number of grafts and bypasses open without stenosis, stenotic, and 
occluded, respectively. Their relative proportions (%) are given on the ordinate. n.d: distal 
segments of sequence grafts that were indeterminate due to occlusion of the proximal 
segment. Comparing occlusion rates of radial artery vs. IMA grafts, P = 0.05, for 
corresponding bypasses, P = 0.10, for radial artery vs. saphenous vein grafts, P = 0.45, for 
corresponding bypasses, P = 0.73 (chi square testa). 
 
Figure 4. Durability of bypasses 
Among 119 patients operated with a radial artery graft to the coronary circulation, 104 (87 %) 
were subjected to direct angiography per study protocol after 1.3 – 3.9 [1] (102 patients) 
and/or after 7.6 – 12.1 years (Fig. 2) (76 patients). Depicted is a Kaplan-Meier time-to-event 
analysis which includes all and exclusively those 300 conduits (97 left internal mammary 
artery (LIMA), 104 radial artery, 86 saphenous vein, and 13 right internal mammary artery 
(RIMA) grafts) which were angiographed per protocol, indicating the interval between the 
index operation and the first per protocol angiography documenting graft occlusion (for 
sequence grafts, occlusion of ≥ 1 bypass). The time points of the last per protocol 
demonstration of non-occlusion were censored. The estimated mean patency (i.e., graft not 
occluded) with 95 % confidence interval of the various graft types were: LIMA: 3670 (3570-
3770) days; radial artery: 3053 (2805-3300) days; saphenous vein: 3324 (3100-3547) days; 
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